Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Maintenance & Consolidation Therapy Trials Landscape
Maintenance therapy clinical trials aim to consolidate deep remission post-ASCT or induction, extend progression-free survival, and investigate MRD-guided de-escalation strategies.
As of 2026-09-04, there are 1 active interventional trials dedicated to this patient population in China.
Clinical Characteristics & Guidance
Studies investigate next-generation oral immunomodulators, proteasome inhibitors, and CD38-directed monoclonal antibodies for prolonged remissions.
Long-term safety, infection prevention, and health-related quality of life are primary assessment endpoints.
MRD-guided trials utilize next-generation sequencing and high-sensitivity flow cytometry to evaluate individualized treatment cessation.
Active Studies (1)
Population synthesized by CMDNShowing 1 published English records of 1 registry trials.